Glutathione (Injectable)
Injectable form of the tripeptide glutathione (Glu-Cys-Gly), the body's primary endogenous antioxidant. IV elimination half-life ~14 minutes with rapid oxidation to GSSG. Administered IV or IM for antioxidant support, detoxification, and skin brightening. Despite very short half-life, replenishes intracellular glutathione stores for prolonged effect.
Projected serum levels — 600 mg, weekly
Maintenance schedule: 600 mg weekly (iv).
Modeled steady state after ~7 days: peak ≈ 72.6 mg, trough ≈ 0.000 mg body load. Population-based estimate over 21 days for a 600 mg dose at a 70 kg reference body mass — the interactive app scales curves to your doses, timing, and body mass.
Key facts
- Category
- Peptide
- Route modeled
- IV
- Model confidence
- inferred
- Half-life
- 14 min
- Common dose
- 600 mg
- Suggested maximum
- 2k mg/day
- Reference dose range
- 300–2k mg (single dose)
- Suggested cadence
- weekly
Documented interactions
-
watch
Astaxanthin + Glutathione (Injectable)
Astaxanthin and Glutathione (Injectable) both push the nrf2 in the same direction.
-
watch
Black Seed Oil (Nigella sativa / Thymoquinone) + Glutathione (Injectable)
Black Seed Oil (Nigella sativa / Thymoquinone) and Glutathione (Injectable) both push the nrf2 in the same direction.
-
watch
Dimethyl Fumarate (Tecfidera) + Glutathione (Injectable)
Dimethyl Fumarate (Tecfidera) and Glutathione (Injectable) both push the nrf2 in the same direction.
-
watch
Green Tea Extract (Camellia sinensis) + Glutathione (Injectable)
Glutathione (Injectable) and Green Tea Extract (Camellia sinensis) both push the nrf2 in the same direction.
-
watch
Milk Thistle (Silymarin / Silybin) + Glutathione (Injectable)
Glutathione (Injectable) and Milk Thistle (Silymarin / Silybin) both push the endogenous glutathione pool in the same direction.
-
watch
N-Acetyl Cysteine (NAC) + Glutathione (Injectable)
Glutathione (Injectable) and N-Acetyl Cysteine (NAC) both push the endogenous glutathione pool in the same direction.
Serum checks 12 modeled interaction pairings for glutathione (injectable) across your whole stack — absorption conflicts, enzyme inhibition, and nutrient depletion included.
Research behind this entry
-
High-dose intravenous glutathione in man: pharmacokinetics and effects on cyst(e)ine in plasma and urine
Key human PK study showing IV glutathione elimination half-life of 14.1 +/- 9.2 min with rapid appearance of cysteine and cystine metabolites in plasma, establishing the basis for IV glutathione dosing.
-
Pharmacokinetics of Glutathione and Its Metabolites in Normal Subjects
Characterized glutathione and metabolite pharmacokinetics in healthy volunteers, establishing baseline parameters for therapeutic glutathione administration.
2 published studies referenced in the app, each with a plain-language summary.